[email protected] +357 96 030922 Contact Us | FAQ |
Advanced search

Pharmaceuticals Market Research Reports & Industry Analysis

Publications found: 36,694
Sort by:

Burkitt Lymphoma (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Burkitt Lymphoma (Oncology) - Drugs in Development, 2021 SUMMARY Burkitt Lymphoma (Oncology) - Drugs in Development, 2021 provides an overview of the Burkitt Lymphoma pipeline landscape. The report pr...

April 2021 110 pages

C-C Chemokine Receptor Type 2 (Monocyte Chemoattractant Protein 1 Receptor or CD192 or CCR2) - Drugs in Development, 2021

 US$ 3,000.00

C-C Chemokine Receptor Type 2 (Monocyte Chemoattractant Protein 1 Receptor or CD192 or CCR2) - Drugs in Development, 2021 SUMMARY C-C Chemokine Receptor Type 2 (Monocyte Chemoattractant Protein 1 Rece...

April 2021 35 pages

C-C Chemokine Receptor Type 9 (G Protein Coupled Receptor 28 or GPR 9-6 or CDw199 or CCR9) - Drugs in Development, 2021

 US$ 3,000.00

C-C Chemokine Receptor Type 9 (G Protein Coupled Receptor 28 or GPR 9-6 or CDw199 or CCR9) - Drugs in Development, 2021 SUMMARY C-C Chemokine Receptor Type 9 (G Protein Coupled Receptor 28 or GPR 9-6...

April 2021 30 pages

Cachexia (Musculoskeletal) - Drugs in Development, 2021

 US$ 2,000.00

Cachexia (Musculoskeletal) - Drugs in Development, 2021 SUMMARY Cachexia (Musculoskeletal) - Drugs in Development, 2021 provides an overview of the Cachexia pipeline landscape. The report provides com...

April 2021 50 pages

Calcineurin (Protein Serine/Threonine Phosphatase 3 or Protein Phosphatase 3 or EC 3.1.3.16) - Drugs in Development, 2021

 US$ 3,000.00

Calcineurin (Protein Serine/Threonine Phosphatase 3 or Protein Phosphatase 3 or EC 3.1.3.16) - Drugs in Development, 2021 SUMMARY Calcineurin (Protein Serine/Threonine Phosphatase 3 or Protein Phospha...

April 2021 80 pages

Calcium Activated Neutral Protease (Calpain or CANP or CAPN or EC 3.4.22.) - Drugs in Development, 2021

 US$ 3,000.00

Calcium Activated Neutral Protease (Calpain or CANP or CAPN or EC 3.4.22.) - Drugs in Development, 2021 SUMMARY Calcium Activated Neutral Protease (Calpain or CANP or CAPN or EC 3.4.22.) - Drugs in De...

April 2021 30 pages

Calcium Activated Potassium Channel - Drugs in Development, 2021

 US$ 3,000.00

Calcium Activated Potassium Channel - Drugs in Development, 2021 SUMMARY Calcium Activated Potassium Channel - Drugs in Development, 2021 provides in depth analysis on Calcium Activated Potassium Chan...

April 2021 35 pages

Calcium Release Activated Calcium Channel Protein 1 (Protein Orai 1 or Transmembrane Protein 142A or ORAI1) - Drugs in Development, 2021

 US$ 3,000.00

Calcium Release Activated Calcium Channel Protein 1 (Protein Orai 1 or Transmembrane Protein 142A or ORAI1) - Drugs in Development, 2021 SUMMARY Calcium Release Activated Calcium Channel Protein 1 (Pr...

April 2021 40 pages

Calcium Sensing Receptor - Drugs in Development, 2021

 US$ 3,000.00

Calcium Sensing Receptor - Drugs in Development, 2021 SUMMARY Calcium Sensing Receptor - Drugs in Development, 2021 provides in depth analysis on Calcium Sensing Receptor targeted pipeline therapeutic...

April 2021 35 pages

Calcium/Calmodulin Dependent Protein Kinase Type II (CAMK2 or EC 2.7.11.17) - Drugs in Development, 2021

 US$ 3,000.00

Calcium/Calmodulin Dependent Protein Kinase Type II (CAMK2 or EC 2.7.11.17) - Drugs in Development, 2021 SUMMARY Calcium/Calmodulin Dependent Protein Kinase Type II (CAMK2 or EC 2.7.11.17) - Drugs in...

April 2021 35 pages

Calreticulin (Calregulin or Endoplasmic Reticulum Resident Protein 60 or CRP55 or HACBP or grp60 or CALR) - Drugs in Development, 2021

 US$ 3,000.00

Calreticulin (Calregulin or Endoplasmic Reticulum Resident Protein 60 or CRP55 or HACBP or grp60 or CALR) - Drugs in Development, 2021 SUMMARY Calreticulin (Calregulin or Endoplasmic Reticulum Residen...

April 2021 35 pages

cAMP Specific 3',5' Cyclic Phosphodiesterase 4B (DPDE4 or PDE32 or PDE4B or EC 3.1.4.53) - Drugs in Development, 2021

 US$ 3,000.00

cAMP Specific 3',5' Cyclic Phosphodiesterase 4B (DPDE4 or PDE32 or PDE4B or EC 3.1.4.53) - Drugs in Development, 2021 SUMMARY cAMP Specific 3',5' Cyclic Phosphodiesterase 4B (DPDE4 or PDE32 or PDE4B o...

April 2021 30 pages

Cancer/Testis Antigen 1 (Autoimmunogenic Cancer/Testis Antigen NY ESO 1 or Cancer/Testis Antigen 6.1 or L Antigen Family Member 2 or CTAG1A or CTAG1B) - Drugs in Development, 2021

 US$ 3,000.00

Cancer/Testis Antigen 1 (Autoimmunogenic Cancer/Testis Antigen NY ESO 1 or Cancer/Testis Antigen 6.1 or L Antigen Family Member 2 or CTAG1A or CTAG1B) - Drugs in Development, 2021 SUMMARY Cancer/Testi...

April 2021 50 pages

Cannabinoid Receptor 1 (CB1 or CANN6 or CNR1) - Drugs in Development, 2021

 US$ 3,500.00

Cannabinoid Receptor 1 (CB1 or CANN6 or CNR1) - Drugs in Development, 2021 SUMMARY Cannabinoid Receptor 1 (CB1 or CANN6 or CNR1) - Drugs in Development, 2021 provides in depth analysis on Cannabinoid...

April 2021 375 pages

Cannabinoid Receptor 2 (CB2 or CX5 or CNR2) - Drugs in Development, 2021

 US$ 3,500.00

Cannabinoid Receptor 2 (CB2 or CX5 or CNR2) - Drugs in Development, 2021 SUMMARY Cannabinoid Receptor 2 (CB2 or CX5 or CNR2) - Drugs in Development, 2021 provides in depth analysis on Cannabinoid Rece...

April 2021 375 pages

Carbonic Anhydrase 9 (Carbonate Dehydratase IX or pMW1 or Membrane Antigen MN or P54/58N or Renal Cell Carcinoma Associated Antigen G250 or CA9 or EC 4.2.1.1) - Drugs in Development, 2021

 US$ 3,000.00

Carbonic Anhydrase 9 (Carbonate Dehydratase IX or pMW1 or Membrane Antigen MN or P54/58N or Renal Cell Carcinoma Associated Antigen G250 or CA9 or EC 4.2.1.1) - Drugs in Development, 2021 SUMMARY Carb...

April 2021 40 pages

Carbonic Anhydrase (Carbonate Dehydratase or Carbonic Acid Anhydrase or Carboxyanhydrase or CA or EC 4.2.1.1) - Drugs in Development, 2021

 US$ 3,000.00

Carbonic Anhydrase (Carbonate Dehydratase or Carbonic Acid Anhydrase or Carboxyanhydrase or CA or EC 4.2.1.1) - Drugs in Development, 2021 SUMMARY Carbonic Anhydrase (Carbonate Dehydratase or Carbonic...

April 2021 30 pages

Carcinoembryonic Antigen (CEA) - Drugs in Development, 2021

 US$ 3,000.00

Carcinoembryonic Antigen (CEA) - Drugs in Development, 2021 SUMMARY Carcinoembryonic Antigen (CEA) - Drugs in Development, 2021 provides in depth analysis on Carcinoembryonic Antigen (CEA) targeted pi...

April 2021 30 pages

Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 (Carcinoembryonic Antigen or CEA or Meconium Antigen 100 or CD66e or CEACAM5) - Drugs in Development, 2021

 US$ 3,000.00

Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 (Carcinoembryonic Antigen or CEA or Meconium Antigen 100 or CD66e or CEACAM5) - Drugs in Development, 2021 SUMMARY Carcinoembryonic Antigen Re...

April 2021 35 pages

Carcinoid Tumor (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Carcinoid Tumor (Oncology) - Drugs in Development, 2021 SUMMARY Carcinoid Tumor (Oncology) - Drugs in Development, 2021 provides an overview of the Carcinoid Tumor pipeline landscape. The report provi...

April 2021 30 pages

Carcinomas (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Carcinomas (Oncology) - Drugs in Development, 2021 SUMMARY Carcinomas (Oncology) - Drugs in Development, 2021 provides an overview of the Carcinomas pipeline landscape. The report provides comprehensi...

April 2021 45 pages

Cardiometabolic Disease (Metabolic Disorders) - Drugs in Development, 2021

 US$ 2,000.00

Cardiometabolic Disease (Metabolic Disorders) - Drugs in Development, 2021 SUMMARY Cardiometabolic Disease (Metabolic Disorders) - Drugs in Development, 2021 provides an overview of the Cardiometaboli...

April 2021 40 pages

Cardiomyopathy (Cardiovascular) - Drugs in Development, 2021

 US$ 2,000.00

Cardiomyopathy (Cardiovascular) - Drugs in Development, 2021 SUMMARY Cardiomyopathy (Cardiovascular) - Drugs in Development, 2021 provides an overview of the Cardiomyopathy pipeline landscape. The rep...

April 2021 55 pages

Cardiovascular Inflammation (Cardiovascular) - Drugs in Development, 2021

 US$ 2,000.00

Cardiovascular Inflammation (Cardiovascular) - Drugs in Development, 2021 SUMMARY Cardiovascular Inflammation (Cardiovascular) - Drugs in Development, 2021 provides an overview of the Cardiovascular I...

April 2021 30 pages

Cardiovascular Risk Factors (Cardiovascular) - Drugs in Development, 2021

 US$ 2,000.00

Cardiovascular Risk Factors (Cardiovascular) - Drugs in Development, 2021 SUMMARY Cardiovascular Risk Factors (Cardiovascular) - Drugs in Development, 2021 provides an overview of the Cardiovascular R...

April 2021 35 pages

Carotid Artery Stenosis (Cardiovascular) - Drugs in Development, 2021

 US$ 2,000.00

Carotid Artery Stenosis (Cardiovascular) - Drugs in Development, 2021 SUMMARY Carotid Artery Stenosis (Cardiovascular) - Drugs in Development, 2021 provides an overview of the Carotid Artery Stenosis...

April 2021 30 pages

Cartilage Degeneration (Musculoskeletal) - Drugs in Development, 2021

 US$ 2,000.00

Cartilage Degeneration (Musculoskeletal) - Drugs in Development, 2021 SUMMARY Cartilage Degeneration (Musculoskeletal) - Drugs in Development, 2021 provides an overview of the Cartilage Degeneration p...

April 2021 40 pages

Casein Kinase 2 (CSNK2 or EC 2.7.11.1) - Drugs in Development, 2021

 US$ 3,000.00

Casein Kinase 2 (CSNK2 or EC 2.7.11.1) - Drugs in Development, 2021 SUMMARY Casein Kinase 2 (CSNK2 or EC 2.7.11.1) - Drugs in Development, 2021 provides in depth analysis on Casein Kinase 2 (CSNK2 or...

April 2021 35 pages

Casein Kinase I Isoform Alpha (CKI Alpha or CK1 or CSNK1A1 or EC 2.7.11.1) - Drugs in Development, 2021

 US$ 3,000.00

Casein Kinase I Isoform Alpha (CKI Alpha or CK1 or CSNK1A1 or EC 2.7.11.1) - Drugs in Development, 2021 SUMMARY Casein Kinase I Isoform Alpha (CKI Alpha or CK1 or CSNK1A1 or EC 2.7.11.1) - Drugs in De...

April 2021 35 pages

Casein Kinase I Isoform Delta (Tau Protein Kinase CSNK1D or CKI Delta or CSNK1D or EC 2.7.11.1 or EC 2.7.11.26) - Drugs in Development, 2021

 US$ 3,000.00

Casein Kinase I Isoform Delta (Tau Protein Kinase CSNK1D or CKI Delta or CSNK1D or EC 2.7.11.1 or EC 2.7.11.26) - Drugs in Development, 2021 SUMMARY Casein Kinase I Isoform Delta (Tau Protein Kinase C...

April 2021 30 pages

Caspase 1 (Interleukin 1 Beta Convertase or Interleukin 1 Beta Converting Enzyme or p45 or CASP1 or EC 3.4.22.36) - Drugs in Development, 2021

 US$ 3,000.00

Caspase 1 (Interleukin 1 Beta Convertase or Interleukin 1 Beta Converting Enzyme or p45 or CASP1 or EC 3.4.22.36) - Drugs in Development, 2021 SUMMARY Caspase 1 (Interleukin 1 Beta Convertase or Inter...

April 2021 35 pages

Caspase (CASP or EC 3.4.22.) - Drugs in Development, 2021

 US$ 3,000.00

Caspase (CASP or EC 3.4.22.) - Drugs in Development, 2021 SUMMARY Caspase (CASP or EC 3.4.22.) - Drugs in Development, 2021 provides in depth analysis on Caspase (CASP or EC 3.4.22.) targeted pipeline...

April 2021 30 pages

CD276 Antigen (B7 Homolog 3 or 4Ig B7 H3 or Costimulatory Molecule or CD276) - Drugs in Development, 2021

 US$ 3,000.00

CD276 Antigen (B7 Homolog 3 or 4Ig B7 H3 or Costimulatory Molecule or CD276) - Drugs in Development, 2021 SUMMARY CD276 Antigen (B7 Homolog 3 or 4Ig B7 H3 or Costimulatory Molecule or CD276) - Drugs i...

April 2021 30 pages

CD44 Antigen (CDw44 or Epican or Extracellular Matrix Receptor III or GP90 Lymphocyte Homing/Adhesion Receptor or HUTCH I or Heparan Sulfate Proteoglycan or Hermes Antigen or Hyaluronate Receptor or Phagocytic Glycoprotein 1 or CD44) - Drugs in Development, 2021

 US$ 3,000.00

CD44 Antigen (CDw44 or Epican or Extracellular Matrix Receptor III or GP90 Lymphocyte Homing/Adhesion Receptor or HUTCH I or Heparan Sulfate Proteoglycan or Hermes Antigen or Hyaluronate Receptor or P...

April 2021 35 pages

Cell Division Control Protein 42 Homolog (G25K GTP Binding Protein or Small GTP Binding Protein CDC42 or CDC42) - Drugs in Development, 2021

 US$ 3,000.00

Cell Division Control Protein 42 Homolog (G25K GTP Binding Protein or Small GTP Binding Protein CDC42 or CDC42) - Drugs in Development, 2021 SUMMARY Cell Division Control Protein 42 Homolog (G25K GTP...

April 2021 30 pages

Cells Expressing ADP Ribosyl Cyclase/Cyclic ADP Ribose Hydrolase 1 (Cyclic ADP Ribose Hydrolase 1 or T10 or 2' Phospho ADP Ribosyl Cyclase/2' Phospho Cyclic ADP Ribose Transferase or ADP Ribosyl Cyclase 1 or CD38 or EC 3.2.2.6 or EC 2.4.99.20) - Drugs in Development, 2021

 US$ 3,000.00

Cells Expressing ADP Ribosyl Cyclase/Cyclic ADP Ribose Hydrolase 1 (Cyclic ADP Ribose Hydrolase 1 or T10 or 2' Phospho ADP Ribosyl Cyclase/2' Phospho Cyclic ADP Ribose Transferase or ADP Ribosyl Cycla...

April 2021 90 pages

Cells Expressing ALK Tyrosine Kinase Receptor (Anaplastic Lymphoma Kinase or CD246 or ALK or EC 2.7.10.1) - Drugs in Development, 2021

 US$ 3,000.00

Cells Expressing ALK Tyrosine Kinase Receptor (Anaplastic Lymphoma Kinase or CD246 or ALK or EC 2.7.10.1) - Drugs in Development, 2021 SUMMARY Cells Expressing ALK Tyrosine Kinase Receptor (Anaplastic...

April 2021 30 pages

Cells Expressing Alpha Fetoprotein (Alpha 1 Fetoprotein or Alpha Fetoglobulin or AFP) - Drugs in Development, 2021

 US$ 3,000.00

Cells Expressing Alpha Fetoprotein (Alpha 1 Fetoprotein or Alpha Fetoglobulin or AFP) - Drugs in Development, 2021 SUMMARY Cells Expressing Alpha Fetoprotein (Alpha 1 Fetoprotein or Alpha Fetoglobulin...

April 2021 35 pages

Cells Expressing Cancer/Testis Antigen 1 (Autoimmunogenic Cancer/Testis Antigen NY ESO 1 or Cancer/Testis Antigen 6.1 or L Antigen Family Member 2 or CTAG1A or CTAG1B) - Drugs in Development, 2021

 US$ 3,000.00

Cells Expressing Cancer/Testis Antigen 1 (Autoimmunogenic Cancer/Testis Antigen NY ESO 1 or Cancer/Testis Antigen 6.1 or L Antigen Family Member 2 or CTAG1A or CTAG1B) - Drugs in Development, 2021 SUM...

April 2021 85 pages

Cells Expressing CD276 Antigen (B7 Homolog 3 or 4Ig B7 H3 or Costimulatory Molecule or CD276) - Drugs in Development, 2021

 US$ 3,000.00

Cells Expressing CD276 Antigen (B7 Homolog 3 or 4Ig B7 H3 or Costimulatory Molecule or CD276) - Drugs in Development, 2021 SUMMARY Cells Expressing CD276 Antigen (B7 Homolog 3 or 4Ig B7 H3 or Costimul...

April 2021 60 pages

Cells Expressing CD3 - Drugs in Development, 2021

 US$ 3,000.00

Cells Expressing CD3 - Drugs in Development, 2021 SUMMARY Cells Expressing CD3 - Drugs in Development, 2021 provides in depth analysis on Cells Expressing CD3 targeted pipeline therapeutics. The repor...

April 2021 35 pages

Cells Expressing CD44 Antigen (CDw44 or Epican or Extracellular Matrix Receptor III or GP90 Lymphocyte Homing/Adhesion Receptor or HUTCH I or Heparan Sulfate Proteoglycan or Hermes Antigen or Hyaluronate Receptor or Phagocytic Glycoprotein 1 or CD44) - Drugs in Development, 2021

 US$ 3,000.00

Cells Expressing CD44 Antigen (CDw44 or Epican or Extracellular Matrix Receptor III or GP90 Lymphocyte Homing/Adhesion Receptor or HUTCH I or Heparan Sulfate Proteoglycan or Hermes Antigen or Hyaluron...

April 2021 35 pages

Cells Expressing CD70 Antigen (CD27 Ligand or Tumor Necrosis Factor Ligand Superfamily Member 7 or CD70) - Drugs in Development, 2021

 US$ 3,000.00

Cells Expressing CD70 Antigen (CD27 Ligand or Tumor Necrosis Factor Ligand Superfamily Member 7 or CD70) - Drugs in Development, 2021 SUMMARY Cells Expressing CD70 Antigen (CD27 Ligand or Tumor Necros...

April 2021 35 pages

Cells Expressing Claudin 18 (CLDN18) - Drugs in Development, 2021

 US$ 3,000.00

Cells Expressing Claudin 18 (CLDN18) - Drugs in Development, 2021 SUMMARY Cells Expressing Claudin 18 (CLDN18) - Drugs in Development, 2021 provides in depth analysis on Cells Expressing Claudin 18 (C...

April 2021 60 pages

Cells Expressing Cytotoxic T Lymphocyte Protein 4 (Cytotoxic T Lymphocyte Associated Antigen 4 or CD152 or CTLA4) - Drugs in Development, 2021

 US$ 3,000.00

Cells Expressing Cytotoxic T Lymphocyte Protein 4 (Cytotoxic T Lymphocyte Associated Antigen 4 or CD152 or CTLA4) - Drugs in Development, 2021 SUMMARY Cells Expressing Cytotoxic T Lymphocyte Protein 4...

April 2021 30 pages

Cells Expressing Delta Like Protein 3 (Drosophila Delta Homolog 3 or DLL3) - Drugs in Development, 2021

 US$ 3,000.00

Cells Expressing Delta Like Protein 3 (Drosophila Delta Homolog 3 or DLL3) - Drugs in Development, 2021 SUMMARY Cells Expressing Delta Like Protein 3 (Drosophila Delta Homolog 3 or DLL3) - Drugs in De...

April 2021 35 pages

Cells Expressing Folate Receptor (FOLR) - Drugs in Development, 2021

 US$ 3,000.00

Cells Expressing Folate Receptor (FOLR) - Drugs in Development, 2021 SUMMARY Cells Expressing Folate Receptor (FOLR) - Drugs in Development, 2021 provides in depth analysis on Cells Expressing Folate...

April 2021 30 pages

Cells Expressing Glypican 3 (Heparan Sulphate Proteoglycan or Intestinal Protein OCI 5 or GTR2 2 or MXR7 or GPC3) - Drugs in Development, 2021

 US$ 3,000.00

Cells Expressing Glypican 3 (Heparan Sulphate Proteoglycan or Intestinal Protein OCI 5 or GTR2 2 or MXR7 or GPC3) - Drugs in Development, 2021 SUMMARY Cells Expressing Glypican 3 (Heparan Sulphate Pro...

April 2021 80 pages

Cells Expressing GTPase KRas (KRas 2 or Ki Ras or c K Ras or KRAS or EC 3.6.5.2) - Drugs in Development, 2021

 US$ 3,000.00

Cells Expressing GTPase KRas (KRas 2 or Ki Ras or c K Ras or KRAS or EC 3.6.5.2) - Drugs in Development, 2021 SUMMARY Cells Expressing GTPase KRas (KRas 2 or Ki Ras or c K Ras or KRAS or EC 3.6.5.2) -...

April 2021 35 pages

Cells Expressing Hepatocyte Growth Factor Receptor (Proto Oncogene c Met or Tyrosine Protein Kinase Met or HGF/SF Receptor or Scatter Factor Receptor or MET or EC 2.7.10.1) - Drugs in Development, 2021

 US$ 3,000.00

Cells Expressing Hepatocyte Growth Factor Receptor (Proto Oncogene c Met or Tyrosine Protein Kinase Met or HGF/SF Receptor or Scatter Factor Receptor or MET or EC 2.7.10.1) - Drugs in Development, 202...

April 2021 35 pages

Filters

Clear all

Search

Categories

153
299
490
372
93
184
386
14,910
12,134
222
1,273
225
433
345
3,983
72
1,120

Publishers

2,237
1,678
72
37
1
4,083
2,049
451
220
650
292
33
4
2,631
796
123
12
81
339
120
1,132
5
6
6
23
18
40
259
30
34
6,128
13
12
142
363
8
25
84
660
8
14
8
49
197
7
2,296
266
579
2,792
7
24
44
31
54
92
7
2,538
40
34
11
22
16
38
2
4
97
4
26
50
1
214
11
120
36
21
227
32
50
27
32
42
878
54
326
51
88
92
60
37
2
14
22
2

Regions

102
85
28
27
26
26
17
14
10
9
7
7
7
7
6
5
3
3
2
2
1
1,629
258
224
198
178
117
113
104
78
73
61
53
42
42
39
36
35
33
30
30
29
29
20
20
20
19
18
18
17
15
15
15
14
13
13
13
13
13
12
12
12
12
12
11
11
11
11
11
10
10
10
9
7
6
6
5
201
260
22
21
883
256
141
68
57
34
29
6
6
6
6
5
5
4
3
3
5
5
5
4
3
2
1
1
1
1
2
2
462
29,919

Price

—

Date

—

Pages

—

Offers

44
5
1